Therapeutic effect of ursolic acid in experimental visceral leishmaniasis

Detalhes bibliográficos
Autor(a) principal: Jesus, Jéssica A.
Data de Publicação: 2017
Outros Autores: Fragoso, Thais N., Yamamoto, Eduardo S., Laurenti, Márcia D., Silva, Marcelo S., Ferreira, Aurea F., Lago, João Henrique G., Gomes, Gabriela S., Passero, Luiz Felipe D. [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1016/j.ijpddr.2016.12.002
http://hdl.handle.net/11449/173906
Resumo: Leishmaniasis is an important neglected tropical disease, affecting more than 12 million people worldwide. The available treatments are not well tolerated and present diverse side effects in patients, justifying the search for new therapeutic compounds. In the present study, the therapeutic potential and toxicity of ursolic acid (UA), isolated from the leaves of Baccharis uncinella C. DC. (Asteraceae), were evaluated in experimental visceral leishmaniasis. To evaluate the therapeutic potential of UA, hamsters infected with L. (L.) infantum were treated daily during 15 days with 1.0 or 2.0 mg UA/kg body weight, or with 5.0 mg amphotericin B/kg body weight by intraperitoneal route. Fifteen days after the last dose, the parasitism of the spleen and liver was stimated and the main histopathological alterations were recorded. The proliferation of splenic mononuclear cells was evaluated and IFN-γ, IL-4, and IL-10 gene expressions were analyzed in spleen fragments. The toxicity of UA and amphotericin B were evaluated in healthy golden hamsters by histological analysis and biochemical parameters. Animals treated with UA had less parasites in the spleen and liver when compared with the infected control group, and they also showed preservation of white and red pulps, which correlate with a high rate of proliferation of splenic mononuclear cells, IFN-γ mRNA and iNOS production. Moreover, animals treated with UA did not present alterations in the levels of AST, ALT, creatinine and urea. Taken together, these findings indicate that UA is an interesting natural compound that should be considered for the development of prototype drugs against visceral leishmaniasis.
id UNSP_19628097bd6fff54cc3388a34af2e865
oai_identifier_str oai:repositorio.unesp.br:11449/173906
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Therapeutic effect of ursolic acid in experimental visceral leishmaniasisLeishmania (Leishmania) infantumTherapeutic potentialToxicityUrsolic acidLeishmaniasis is an important neglected tropical disease, affecting more than 12 million people worldwide. The available treatments are not well tolerated and present diverse side effects in patients, justifying the search for new therapeutic compounds. In the present study, the therapeutic potential and toxicity of ursolic acid (UA), isolated from the leaves of Baccharis uncinella C. DC. (Asteraceae), were evaluated in experimental visceral leishmaniasis. To evaluate the therapeutic potential of UA, hamsters infected with L. (L.) infantum were treated daily during 15 days with 1.0 or 2.0 mg UA/kg body weight, or with 5.0 mg amphotericin B/kg body weight by intraperitoneal route. Fifteen days after the last dose, the parasitism of the spleen and liver was stimated and the main histopathological alterations were recorded. The proliferation of splenic mononuclear cells was evaluated and IFN-γ, IL-4, and IL-10 gene expressions were analyzed in spleen fragments. The toxicity of UA and amphotericin B were evaluated in healthy golden hamsters by histological analysis and biochemical parameters. Animals treated with UA had less parasites in the spleen and liver when compared with the infected control group, and they also showed preservation of white and red pulps, which correlate with a high rate of proliferation of splenic mononuclear cells, IFN-γ mRNA and iNOS production. Moreover, animals treated with UA did not present alterations in the levels of AST, ALT, creatinine and urea. Taken together, these findings indicate that UA is an interesting natural compound that should be considered for the development of prototype drugs against visceral leishmaniasis.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Laboratory of Pathology of Infectious Diseases (LIM50) Department of Pathology Medical School of São Paulo University, Av. Dr. Arnaldo, 455. Cerqueira CésarCenter of Natural Sciences and Humanities Federal University of ABCGlobal Health and Tropical Medicine Instituto de Higiene e Medicina Tropical (IHMT) Universidade Nova de Lisboa, Rua da Junqueira 100Departamento de Análises Clínicas e Toxicológicas Centro de Ciências da Saúde Universidade Federal do Rio Grande do Norte, Rua General Gustavo Cordeiro de Farias, 384São Paulo State University (Unesp) Institute of Biosciences São Vicente, Praça Infante Dom Henrique, s/nSão Paulo State University (Unesp) Institute of Biosciences São Vicente, Praça Infante Dom Henrique, s/nFAPESP: 2013/10133-8FAPESP: 2013/16297-2FAPESP: 2015/11936-2FAPESP: 2016/00468-0Universidade de São Paulo (USP)Federal University of ABCUniversidade Nova de LisboaUniversidade Federal do Rio Grande do NorteUniversidade Estadual Paulista (Unesp)Jesus, Jéssica A.Fragoso, Thais N.Yamamoto, Eduardo S.Laurenti, Márcia D.Silva, Marcelo S.Ferreira, Aurea F.Lago, João Henrique G.Gomes, Gabriela S.Passero, Luiz Felipe D. [UNESP]2018-12-11T17:08:17Z2018-12-11T17:08:17Z2017-04-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article1-11application/pdfhttp://dx.doi.org/10.1016/j.ijpddr.2016.12.002International Journal for Parasitology: Drugs and Drug Resistance, v. 7, n. 1, p. 1-11, 2017.2211-3207http://hdl.handle.net/11449/17390610.1016/j.ijpddr.2016.12.0022-s2.0-850040929862-s2.0-85004092986.pdfScopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengInternational Journal for Parasitology: Drugs and Drug Resistance1,556info:eu-repo/semantics/openAccess2023-10-19T06:03:43Zoai:repositorio.unesp.br:11449/173906Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T15:17:17.800910Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Therapeutic effect of ursolic acid in experimental visceral leishmaniasis
title Therapeutic effect of ursolic acid in experimental visceral leishmaniasis
spellingShingle Therapeutic effect of ursolic acid in experimental visceral leishmaniasis
Jesus, Jéssica A.
Leishmania (Leishmania) infantum
Therapeutic potential
Toxicity
Ursolic acid
title_short Therapeutic effect of ursolic acid in experimental visceral leishmaniasis
title_full Therapeutic effect of ursolic acid in experimental visceral leishmaniasis
title_fullStr Therapeutic effect of ursolic acid in experimental visceral leishmaniasis
title_full_unstemmed Therapeutic effect of ursolic acid in experimental visceral leishmaniasis
title_sort Therapeutic effect of ursolic acid in experimental visceral leishmaniasis
author Jesus, Jéssica A.
author_facet Jesus, Jéssica A.
Fragoso, Thais N.
Yamamoto, Eduardo S.
Laurenti, Márcia D.
Silva, Marcelo S.
Ferreira, Aurea F.
Lago, João Henrique G.
Gomes, Gabriela S.
Passero, Luiz Felipe D. [UNESP]
author_role author
author2 Fragoso, Thais N.
Yamamoto, Eduardo S.
Laurenti, Márcia D.
Silva, Marcelo S.
Ferreira, Aurea F.
Lago, João Henrique G.
Gomes, Gabriela S.
Passero, Luiz Felipe D. [UNESP]
author2_role author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade de São Paulo (USP)
Federal University of ABC
Universidade Nova de Lisboa
Universidade Federal do Rio Grande do Norte
Universidade Estadual Paulista (Unesp)
dc.contributor.author.fl_str_mv Jesus, Jéssica A.
Fragoso, Thais N.
Yamamoto, Eduardo S.
Laurenti, Márcia D.
Silva, Marcelo S.
Ferreira, Aurea F.
Lago, João Henrique G.
Gomes, Gabriela S.
Passero, Luiz Felipe D. [UNESP]
dc.subject.por.fl_str_mv Leishmania (Leishmania) infantum
Therapeutic potential
Toxicity
Ursolic acid
topic Leishmania (Leishmania) infantum
Therapeutic potential
Toxicity
Ursolic acid
description Leishmaniasis is an important neglected tropical disease, affecting more than 12 million people worldwide. The available treatments are not well tolerated and present diverse side effects in patients, justifying the search for new therapeutic compounds. In the present study, the therapeutic potential and toxicity of ursolic acid (UA), isolated from the leaves of Baccharis uncinella C. DC. (Asteraceae), were evaluated in experimental visceral leishmaniasis. To evaluate the therapeutic potential of UA, hamsters infected with L. (L.) infantum were treated daily during 15 days with 1.0 or 2.0 mg UA/kg body weight, or with 5.0 mg amphotericin B/kg body weight by intraperitoneal route. Fifteen days after the last dose, the parasitism of the spleen and liver was stimated and the main histopathological alterations were recorded. The proliferation of splenic mononuclear cells was evaluated and IFN-γ, IL-4, and IL-10 gene expressions were analyzed in spleen fragments. The toxicity of UA and amphotericin B were evaluated in healthy golden hamsters by histological analysis and biochemical parameters. Animals treated with UA had less parasites in the spleen and liver when compared with the infected control group, and they also showed preservation of white and red pulps, which correlate with a high rate of proliferation of splenic mononuclear cells, IFN-γ mRNA and iNOS production. Moreover, animals treated with UA did not present alterations in the levels of AST, ALT, creatinine and urea. Taken together, these findings indicate that UA is an interesting natural compound that should be considered for the development of prototype drugs against visceral leishmaniasis.
publishDate 2017
dc.date.none.fl_str_mv 2017-04-01
2018-12-11T17:08:17Z
2018-12-11T17:08:17Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1016/j.ijpddr.2016.12.002
International Journal for Parasitology: Drugs and Drug Resistance, v. 7, n. 1, p. 1-11, 2017.
2211-3207
http://hdl.handle.net/11449/173906
10.1016/j.ijpddr.2016.12.002
2-s2.0-85004092986
2-s2.0-85004092986.pdf
url http://dx.doi.org/10.1016/j.ijpddr.2016.12.002
http://hdl.handle.net/11449/173906
identifier_str_mv International Journal for Parasitology: Drugs and Drug Resistance, v. 7, n. 1, p. 1-11, 2017.
2211-3207
10.1016/j.ijpddr.2016.12.002
2-s2.0-85004092986
2-s2.0-85004092986.pdf
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv International Journal for Parasitology: Drugs and Drug Resistance
1,556
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 1-11
application/pdf
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1808128493878247424